Cell based assays indicated a predominant effect of GSK3α knockdown in prostate cancer cells on cell survival, proliferation and tumor growth with only a modest or no effect of GSK3β knockdown on these cell functions. The gene discussed is GSK3B; the disease is neoplasm.